PSA

(redirected from prostate-specific antigen)
Also found in: Dictionary, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for PSA

a protein manufactured exclusively by the prostate gland

References in periodicals archive ?
Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice.
Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.
Prostate-specific antigen is a protein produced by the prostate gland.
Prostate-specific antigen and PSA free/total ratio are currently the most reliable serum markers.
Measurement of the proportion of free-to-to-tal prostate-specific antigen improves diagnostic perfor-mance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
Clinical question How often should men who choose to have prostate-specific antigen testing be screened?
Investigators reported that PROSTASCINT-guided IMRT led to "appropriate" responses in prostate-specific antigen (PSA) levels; bDFS rates were 98% at 24 months and 92% at 36 months.
The measurement of prostate-specific antigen (PSA) is widely used for prostate cancer screening.
Prostate-specific antigen (PSA), (3) a kallikrein-like serine protease, is one of the most abundant proteins secreted by the prostate into seminal fluid (1).
PHILADELPHIA -- Measuring serum levels of free and complexed prostate-specific antigen may help estimate prostate cancer risk when the total prostate-specific antigen level is indeterminate.
CHICACO -- A prostate-specific antigen threshold of 2.
For instance, physicians look at high blood concentrations of a protein called prostate-specific antigen as an indication of prostate cancer.
Widespread use of a blood test called prostate-specific antigen, or PSA, has reduced the proportion of prostate cancer considered incurable at the time of diagnosis from about 50 percent to 5 percent, Klein said.
Full browser ?